The Impact of Chemotherapy on Oxidant and Antioxidant Status in Acute Lymphoblastic Leukemia
Academic Journal of International University of Erbil · 25.05.2026
DOI: 10.63841/iue3261023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Journal of International University of Erbil, online erschienen am 25.04.2026. Verfasst von Khanda Najat Assaf und 1 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Acute lymphoblastic leukemia (ALL) is a malignant disorder of lymphoid lineage. Chemotherapy remains the mainstay of treatment, yet it induces systemic damage partly through oxidative stress, which may worsen prognosis, increase relapse risk, and impair responsiveness to therapy. A total of 64 individuals participated in the study: 21 newly diagnosed ALL (ND-ALL) patients with a median age of 10 years (IQR 3-27.5), 23 patients receiving maintenance chemotherapy with a median age of 13 years (IQR 5-23), and 20 healthy controls with a median age of 11.5 years (IQR 5-23), (cross-sectional study). Following remission induction treatment, ND-ALL patients were also reassessed (longitudinal study). ELISA kits were used to detect superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), total antioxidant capacity (T-AOC), malondialdehyde (MDA), 8-hydroxy-2′-deoxyguanosine(8-OHdG), and protein carbonyl (PC). In the cross-sectional study, MDA (p = 0.05) and 8-OHdG (p = 0.001) were significantly higher in ND-ALL patients. SOD demonstrated a considerable decline (p = 0.001), the antioxidants GSH-PX and T-AOC also decreased significantly (p = 0.01). There were no significant differences between the maintenance group and the controls. Significant increases in MDA, 8-OHdG, and PC (p = 0.05, 0.01, 0.01, respectively), and decreases in GSH-PX, SOD, and T-AOC (p = 0.01, 0.05, 0.01, respectively) were observed following treatment. Chemotherapy significantly alters the oxidant-antioxidant balance in patients with ALL. Treatment was associated with an increase in oxidative stress markers, accompanied by a marked reduction in antioxidant defense capacity.
Zitieren
APA
Assaf, K. N., & Mohammed, S. I. (2026). The Impact of Chemotherapy on Oxidant and Antioxidant Status in Acute Lymphoblastic Leukemia. Academic Journal of International University of Erbil. https://doi.org/10.63841/iue3261023
Vancouver
Assaf KN, Mohammed SI. The Impact of Chemotherapy on Oxidant and Antioxidant Status in Acute Lymphoblastic Leukemia. Academic Journal of International University of Erbil. 2026. doi:10.63841/iue3261023
BibTeX
@article{Assaf2026,
author = {Assaf, Khanda Najat and Mohammed, Sarbaz Ibrahim},
title = {The Impact of Chemotherapy on Oxidant and Antioxidant Status in Acute Lymphoblastic Leukemia},
journal = {Academic Journal of International University of Erbil},
year = {2026},
doi = {10.63841/iue3261023}
}
EUVIMED